Vaginal Birth After Caesarean (VBAC)

1. Clinical Overview

Summary

Vaginal Birth After Caesarean (VBAC) refers to a planned vaginal delivery for a woman with a history of previous Caesarean Section (CS). The attempt at vaginal delivery is termed Trial of Labour After Caesarean (TOLAC). VBAC represents a safe and viable option for appropriately selected women, with success rates of 72-75% in unselected populations and up to 85-90% in women with a previous vaginal delivery. [1,2]

The principal concern with TOLAC is uterine scar rupture, occurring in approximately 0.5% (1 in 200) of attempted vaginal births after one previous lower segment caesarean section (LSCS). This rare but potentially catastrophic complication necessitates immediate access to emergency operative delivery and appropriate intrapartum monitoring. [3,4]

VBAC offers significant maternal benefits compared to elective repeat caesarean section (ERCS), including reduced surgical morbidity, shorter recovery, decreased risk of placenta accreta spectrum disorders in future pregnancies, and improved outcomes for women desiring large families. Modern evidence-based practice emphasizes informed maternal choice following comprehensive counselling regarding individualised risks and benefits. [5,6]

Exam Detail: Historical Context: The dictum "once a caesarean, always a caesarean" originated from early 20th-century practice when classical (vertical) uterine incisions were standard. The transition to lower segment transverse incisions in the 1960s-70s substantially reduced rupture risk, enabling safe TOLAC for appropriately selected candidates. Current RCOG and ACOG guidelines strongly support offering VBAC to eligible women. [7,8]

Pathophysiological Basis: Uterine scar integrity depends on healing quality following previous CS. Lower segment transverse incisions heal with myometrial remodeling and collagen deposition. Scar strength is influenced by inter-delivery interval, inflammatory processes, surgical technique, and individual healing factors. Rupture occurs when intrauterine pressure during contractions exceeds scar tensile strength, typically at the site of previous hysterotomy. [9]

Clinical Pearls

Success Predictor Hierarchy: Previous vaginal delivery (especially prior VBAC) > spontaneous labour onset > non-recurrent CS indication > BMI less than 30 > estimated fetal weight less than 4kg. Previous vaginal delivery is the strongest positive predictor, increasing success to 85-90%. [2,10]

Rupture Risk Stratification: Spontaneous labour 0.5% → Oxytocin augmentation 0.8-1% → Prostaglandin induction 1.5-2.4%. Misoprostol contraindicated for TOLAC due to 2-3× rupture risk. [3,11]

CTG Changes Precede Clinical Signs: Fetal heart rate abnormalities (prolonged deceleration, bradycardia) typically manifest before maternal symptoms in uterine rupture. Continuous electronic fetal monitoring (CEFM) is mandatory throughout active TOLAC. [12]

"Rupture vs Dehiscence": Complete rupture involves full-thickness uterine wall separation with fetal/placental protrusion and haemorrhage. Uterine dehiscence is incomplete separation (intact serosa/peritoneum) often asymptomatic, discovered incidentally at CS or postpartum. Clinical significance differs markedly. [13]

Inter-delivery Interval Matters: Intervals less than 18-24 months associate with increased rupture risk (adjusted OR 2.3-3.0) due to incomplete scar remodeling. Optimal interval appears to be 18-36 months. [14]

---

2. Epidemiology

Incidence and Prevalence

Demographics and Risk Factors

Factors Associated with VBAC Success: [2,10,15]

Factors Associated with Uterine Rupture: [3,11,14]

Exam Detail: Prediction Models: Several validated calculators estimate individualised VBAC success probability:

1. MFMU VBAC Calculator (Grobman et al., 2007): Incorporates maternal age, BMI, ethnicity, previous vaginal delivery, indication for prior CS, and VBAC attempt history. Validated in > 13,000 women; C-statistic 0.75. [10]

2. Flamm Model (1997): Simpler model using age, previous vaginal delivery, CS indication (recurrent/non-recurrent), cervical dilatation at admission. Good discrimination (C-statistic 0.77). [16]

3. UK Nomogram (Smith et al., 2005): Adds ethnicity, Bishop score, and infant birthweight. Developed from 90,000+ UK deliveries. [15]

These models aid counselling but should complement, not replace, individualised clinical discussion. Women with predicted success > 60-70% generally appropriate for TOLAC; less than 40% may benefit from ERCS discussion.

Ethnic and Geographic Variation

• Ethnicity: African-American and Hispanic women have slightly lower VBAC success rates (68-70%) versus Caucasian women (75-78%), persisting after adjustment for BMI and other factors. Mechanisms unclear. [10]
• Unit Variation: TOLAC rates vary 3-fold between UK units (15-60%), reflecting cultural, resource, and medicolegal differences rather than patient selection alone. [17]
• Socioeconomic Factors: Higher maternal education and socioeconomic status associate with increased TOLAC uptake, potentially reflecting informed decision-making access. [18]

---

3. Aetiology and Pathophysiology

Uterine Scar Biology

Normal Scar Healing:

Following lower segment caesarean section, the myometrial incision undergoes healing through:

1. Haemostasis and Inflammation (0-7 days): Platelet plug formation, inflammatory cell infiltration, fibrin deposition.
2. Proliferation (1-4 weeks): Fibroblast migration, collagen synthesis (initially type III), neovascularization, granulation tissue formation.
3. Remodeling (3-12 months): Collagen maturation (type III → type I transition), cross-linking, scar contraction, myometrial fiber reorganization. [9]

Optimal healing produces a scar with 70-80% tensile strength of intact myometrium by 6-12 months. Lower segment location minimizes contractile stress during subsequent pregnancy.

Factors Impairing Healing:

• Short Inter-Delivery Interval: Pregnancy before complete collagen remodeling (typ. 12-18 months) yields weaker scar. [14]
• Infection: Endometritis/wound infection impairs fibroblast function, increases inflammatory collagenase activity, produces disorganized scar architecture. [9]
• Surgical Technique: Single-layer closure associates with thinner scars on ultrasound versus double-layer; clinical significance debated. [19]
• Ischaemia: Suture placement compromising vascular supply; excessive cautery use.

Mechanism of Uterine Rupture

Rupture Pathophysiology:

Uterine rupture occurs when intrauterine pressure exceeds scar tensile strength:

• Intrauterine Pressure in Labour: Contractions generate 50-100 mmHg pressure (up to 150 mmHg with oxytocin augmentation). Pressures concentrate at weak points (scar). [20]
• Scar Stress Distribution: Finite element modeling shows 3-5× stress concentration at scar edges during contractions, particularly with thin lower segment (less than 2.5mm on ultrasound). [21]
• Progressive Thinning: Gradual scar attenuation during pregnancy and labour may precede complete rupture (explaining some asymptomatic "windows" discovered incidentally).

Complete vs Incomplete Rupture:

Exam Detail: Molecular Biology of Scar Formation:

Recent research elucidates molecular mechanisms:

• Matrix Metalloproteinases (MMPs): MMP-2 and MMP-9 upregulation in scarred myometrium during labour may facilitate collagen degradation and rupture. Elevated amniotic fluid MMP levels correlate with rupture risk. [22]
• Transforming Growth Factor-β (TGF-β): Dysregulated TGF-β signaling in impaired healing produces excessive fibrosis or inadequate collagen deposition. [23]
• Inflammatory Cytokines: IL-6, IL-8, and TNF-α elevation in scar tissue associates with weaker tensile strength in animal models. [24]

These findings may enable future biomarker-based risk stratification, though currently investigational.

Role of Induction Agents

Prostaglandins:

• Mechanism of Increased Risk: Prostaglandins (PGE2, PGF2α) induce intense, frequent contractions with reduced uterine relaxation between contractions, sustaining high intrauterine pressure and scar stress. [11]
• Cervical Ripening Effects: Collagenase activation and cervical remodeling may extend to lower segment scar tissue, weakening integrity.
• Misoprostol: Synthetic PGE1 analogue produces particularly strong, prolonged contractions; rupture risk 2.3-5.7%. Contraindicated for TOLAC per RCOG/ACOG. [8,11]

Oxytocin:

• Lower Risk Profile: Augmentation with oxytocin increases rupture risk modestly (0.8-1.0% vs 0.5% spontaneous). Dose-dependent effect suggests cautious, low-dose protocols. [3]
• Reversibility: IV oxytocin allows rapid cessation if CTG concerns arise, unlike vaginal prostaglandins.

Mechanical Methods:

• Balloon Catheters: Foley catheter or double-balloon devices (Cook catheter) provide cervical ripening without uterotonic effect. Rupture risk similar to spontaneous labour (~0.5%). Preferred induction method for TOLAC. [25]

---

4. Clinical Presentation

Antenatal Assessment

History Taking:

Essential information to elicit:

• Previous Caesarean Section Details:

  • Number of previous CS (1 vs ≥2)
  • "Indication(s): recurrent (cephalopelvic disproportion, failure to progress) vs non-recurrent (breech, fetal distress, placenta praevia)"
  • "Type of uterine incision: Lower segment transverse (LSCS) vs classical/vertical/T/J incision (review operative notes if available)"
  • "Complications: infection, haemorrhage, difficult delivery, uterine extensions"
  • "Closure technique: single vs double-layer (if documented)"

• Obstetric History:

  • Any vaginal deliveries (before or after previous CS)? Critical prognostic factor
  • Previous VBAC attempts and outcomes
  • Inter-delivery interval from last CS
  • Stillbirths, neonatal deaths (may influence mode of delivery preference)

• Current Pregnancy:

  • Estimated fetal weight (macrosomia reduces success)
  • Fetal lie and presentation (malpresentation may preclude TOLAC)
  • Placental location (praevia contraindicates TOLAC)
  • Maternal medical conditions (diabetes, hypertension, etc.)

• Maternal Factors:

  • Age, BMI, ethnicity
  • Maternal preference following information provision

Physical Examination:

• Abdominal Examination: Fundal height, fetal lie/presentation, engagement, estimated weight
• Previous Scar Inspection: Assess previous abdominal incision (usually low transverse Pfannenstiel or Joel-Cohen); vertical scar may indicate classical CS

Intrapartum Presentation (Normal TOLAC Progress)

Latent Phase (0-4 cm):

• Irregular contractions, cervical effacement and early dilatation
• Monitoring: Intermittent auscultation acceptable in latent phase per guidelines (if low-risk otherwise), though many units prefer continuous CTG from admission

Active Phase (4-10 cm):

• Mandatory continuous CTG from 4 cm or active labour onset
• Regular painful contractions (3-4 per 10 minutes)
• Progressive cervical dilatation (expected ~1 cm/hour in primigravid TOLAC; 1.5-2 cm/hour in multigravid)
• Descent of presenting part

Second Stage:

• Full dilatation to delivery
• Passive second stage (full dilatation, no expulsive urge) ≤2 hours acceptable
• Active pushing typically ≤1 hour; senior review if prolonged

Signs of Uterine Rupture (EMERGENCY)

Early Warning Signs (often subtle):

1. Fetal Heart Rate Abnormalities (MOST COMMON PRESENTING SIGN):

   • Prolonged deceleration (> 3 minutes)
   • Sudden-onset bradycardia (less than 110 bpm)
   • Recurrent variable or late decelerations
   • Loss of baseline variability
   • CTG changes typically precede maternal symptoms by 10-30 minutes [12]

2. Maternal Symptoms:

   • Sudden severe abdominal pain (distinct from contraction pain; may describe "tearing" or "popping" sensation)
   • Pain between contractions (normal labour pain is contraction-associated only)
   • Suprapubic or lower abdominal tenderness

3. Abnormal Labour Progress:

   • Cessation of previously normal contractions
   • Loss of station (fetal head disengages)
   • Failure to progress despite adequate contractions

Late/Severe Signs (indicate advanced rupture):

4. Vaginal Bleeding: Bright red blood (may be minimal if intraperitoneal bleeding predominates)
5. Maternal Haemodynamic Compromise:
   • Tachycardia (> 100-110 bpm)
   • Hypotension (less than 90 mmHg systolic)
   • Signs of shock (pallor, diaphoresis, anxiety, reduced consciousness)
6. Abdominal Examination Findings:
   • Loss of uterine contractions (uterus feels soft, atonic)
   • Easily palpable fetal parts (fetus extruded into abdomen)
   • Abdominal distension
   • Peritonism (guarding, rigidity, rebound tenderness)

Clinical Pearl: "The Index of Suspicion" in TOLAC: Maintain heightened awareness throughout labour. Any unexplained fetal heart rate abnormality in TOLAC warrants immediate senior review and consideration of expedited delivery. The threshold for Category 1 CS should be lower than in uncomplicated labour. A "pre-rupture syndrome" may exist with progressive scar thinning causing intermittent CTG changes before frank rupture. [12,13]

Differential Diagnosis of Acute Intrapartum Deterioration

When CTG abnormalities or maternal symptoms arise during TOLAC:

Key Principle: When in doubt, deliver. The consequences of missed uterine rupture are catastrophic. A low threshold for Category 1 CS in TOLAC with CTG concerns is appropriate.

---

5. Investigations

Antenatal Investigations

Review of Previous Operative Notes (ESSENTIAL):

• Confirm type of uterine incision: Lower segment transverse (LSCS) vs classical/inverted T/J incision
  • "If operative notes unavailable: vertical abdominal scar suggests possible classical CS (though not diagnostic); consider imaging"
• Document indication for previous CS
• Note complications: extensions, difficult delivery, excessive bleeding, infection
• Closure technique (if documented)

Transvaginal Ultrasound Measurement of Lower Uterine Segment Thickness (Investigational):

• Rationale: Thin lower segment (less than 2-3 mm at term) may predict rupture risk
• Evidence: Several studies show less than 2.0 mm associates with higher dehiscence rates; however, not currently recommended for routine clinical decision-making due to:
  • Wide measurement variability (operator-dependent)
  • No validated threshold for clinical management
  • Limited predictive value (most thin segments do not rupture; many ruptures occur with normal thickness)
• Potential Role: May inform counselling in borderline cases; research ongoing [21,26]

Standard Antenatal Investigations:

• Routine Pregnancy Bloods: FBC, blood group and antibody screen, infection screening per standard care
• Glucose Screening: Gestational diabetes assessment (macrosomia reduces VBAC success)
• Ultrasound for Fetal Growth and Presentation:
  • "Estimated fetal weight (EFW): > 4000-4500 g may warrant ERCS discussion"
  • Confirm cephalic presentation (breech/transverse precludes TOLAC)
  • Placental location (exclude praevia)

Intrapartum Investigations and Monitoring

Mandatory Monitoring During TOLAC: [8]

Interpretation of CTG in TOLAC:

• Classify as per standard FIGO/NICE criteria (normal, suspicious, pathological)
• Lower threshold for intervention: Suspicious CTG in TOLAC warrants senior review and consideration of expedited delivery
• Features concerning for rupture:
  • Prolonged deceleration (> 3 minutes)
  • Acute bradycardia (less than 100 bpm for > 5 minutes)
  • Sudden loss of variability with decelerations
  • Recurrent late decelerations with slow recovery

Fetal Blood Sampling (FBS) in TOLAC:

• Controversial: Some units avoid FBS in TOLAC due to rupture concerns and preference for expedited CS if suspicious CTG
• RCOG Position: FBS not contraindicated in TOLAC; appropriate if CTG suspicious but clinical situation otherwise reassuring and woman wishes to continue
• Practical Consideration: Time to Category 1 CS may be preferable to FBS in many TOLAC scenarios

Investigations if Rupture Suspected:

• Urgent FBC: Haemoglobin (baseline for anticipated haemorrhage)
• Group and Save / Crossmatch: Ensure blood products available (request 4-6 units if major haemorrhage anticipated)
• Coagulation Screen: Assess for consumptive coagulopathy if massive bleeding
• Bedside Ultrasound (if time permits): May show free fluid, fetal parts outside uterus (rarely performed in practice due to urgency)

Postpartum Assessment (if VBAC successful):

• Manual Exploration of Uterus: Recommended by some practitioners after VBAC to assess scar integrity; detects asymptomatic dehiscence in ~1-2%
  • "Controversy: Not universally practiced; debated benefit vs discomfort/infection risk"
  • "RCOG Guidance: Routine exploration not mandated; consider if clinical concerns (excessive bleeding, abdominal pain)"
• Uterine Palpation: Feel for uterine contour irregularities, defects

---

6. Management

Antenatal Counselling and Decision-Making

Timing of Counselling:

• Booking Visit: Document previous CS; provide initial information
• Detailed Discussion: 34-36 weeks (allow time for informed decision-making)
• Birth Planning: Finalize mode of delivery by 37-38 weeks

Structured Counselling Framework:

1. Establish Eligibility:

   • Confirm previous CS type (LSCS vs classical/unknown)
   • Identify absolute contraindications (see Section 6.2)
   • Assess relative risk factors

2. Provide Individualised Risk Estimates:

   • Use prediction calculator (MFMU/Flamm) to estimate VBAC success probability for this woman
   • Discuss rupture risk specific to her scenario (spontaneous vs induction, previous VD, etc.)
   • Present absolute risks, not just relative (e.g., "5 in 1000" not "2-fold increase")

3. Discuss Benefits of VBAC vs ERCS:

   • See Section 6.3 (detailed comparison table)
   • Emphasize short-term benefits (recovery, avoiding surgery) and long-term implications (future pregnancies, placenta accreta risk with multiple CS)

4. Address Patient-Specific Concerns:

   • Safety perceptions: "Will my baby be safe?"
   • Fear of emergency CS after failed TOLAC ("double risk")
   • Previous traumatic birth experience
   • Future fertility plans (large family vs complete)

5. Elicit Maternal Preference:

   • Informed maternal choice is paramount; support decision-making
   • Document decision in notes
   • Allow time to change mind; review if circumstances change

Communication Tools:

• Decision Aids: RCOG patient information leaflets, visual aids showing risks (icon arrays), online calculators
• Birth Planning Documentation: Complete individualized plan documenting:
  • Mode of delivery choice (TOLAC vs ERCS)
  • "If TOLAC: preferences for pain relief, monitoring, induction (if needed)"
  • Understanding of rupture signs and plan for emergency

Exam Detail: Shared Decision-Making Models in VBAC:

Modern obstetric practice emphasizes shared decision-making rather than physician-directed choice:

• Autonomy Principle: Women have the right to make informed decisions about their care, including accepting or declining recommended interventions
• Non-Directive Counselling: Present balanced information without steering toward particular choice; respect women who choose ERCS despite being "low-risk" for rupture, or TOLAC despite lower predicted success
• Decision Regret: Studies show women are more satisfied with VBAC decisions (successful or not) when they feel involved in decision-making, regardless of outcome [27]

Ethical tensions arise when maternal preference conflicts with clinical recommendations (e.g., woman requesting TOLAC with multiple risk factors, or ERCS with very favorable success prediction). Document discussions thoroughly; involve senior clinicians and ethics support if needed.

Contraindications to TOLAC

Absolute Contraindications:

Relative Contraindications (Individualized Discussion):

Special Scenarios:

• Twins: TOLAC not contraindicated for dichorionic twins with cephalic-presenting Twin 1; success rates slightly lower (~65-70%). Higher-order multiples generally recommend ERCS. [28]
• Breech Presentation: Breech extraction after previous CS carries high risk; recommend ERCS for breech in VBAC candidate.
• Maternal Request for ERCS: Respect autonomy; explore reasons but support decision. Maternal choice alone is acceptable indication for ERCS.

Comparison: VBAC vs Elective Repeat Caesarean Section

Comprehensive Risk-Benefit Analysis: [5,6,8]

Future Pregnancy Implications:

Clinical Pearl: "VBAC Benefit Accumulates with Parity": For women desiring large families (≥3-4 children), successful VBAC is particularly advantageous. Each avoided CS reduces cumulative placenta accreta spectrum risk. Example: Woman desiring 4 children with 1 previous CS:

• VBAC route: 1 CS total → accreta risk ~0.3% for subsequent pregnancies
• Repeat CS route: 4 CS total → accreta risk ~3-6% for 4th pregnancy

This should feature prominently in counselling for younger women with fertility plans. [29]

Intrapartum Management of TOLAC

Setting and Staffing Requirements: [8]

• Consultant-Led Unit: TOLAC must occur in hospital with:

  • Immediate access to Category 1 CS (decision-to-delivery ≤30 minutes)
  • 24/7 on-site anaesthetic cover
  • On-site blood bank with emergency blood protocol
  • Neonatal resuscitation available
  • Operating theatre staffed or immediately available

• Home Birth / Midwife-Led Unit: Contraindicated for TOLAC. Requires consultant unit.

• Staffing: Coordinate care team on admission:

  • Senior obstetrician awareness of TOLAC patient
  • Anaesthetic team notification
  • Neonatology informed (for delivery)

On Admission:

Labour Management:

Monitoring:

• Continuous CTG: Mandatory throughout active labour and second stage. Do not discontinue monitoring in TOLAC.
• Maternal Observations: Hourly minimum (pulse, BP); increase frequency if concerns
• Fluid Balance: Maintain hydration; avoid overload (risk of pulmonary oedema if haemorrhage)

Progress Assessment:

• Vaginal Examination: 4-hourly to assess dilatation and descent
• Partogram: Plot progress; expected rate ~1 cm/hour in multiparous TOLAC (1.5-2 cm/hour if previous VD)
• Action Line: If progress slower than expected, senior review required

Pain Relief:

• Epidural Analgesia: Not contraindicated in TOLAC. Previously thought to "mask rupture pain" but CTG changes precede pain; epidural enables safer instrumental delivery/emergency CS if needed. Encourage if woman desires. [30]
• Opioids, TENS, Entonox: Use as per standard labour; no specific TOLAC restrictions

Slow Progress / Failure to Progress:

• Senior Review: If labour not progressing despite adequate contractions (> 3 per 10 min), consultant obstetrician review
• Oxytocin Augmentation: Permissible in TOLAC but use cautiously:
  • Start low-dose regimen (e.g., 1-2 mU/min, increase by 1-2 mU/min every 30 min)
  • Monitor contractions carefully (avoid hyperstimulation)
  • Increases rupture risk to ~0.8-1.0%
  • Continuous senior awareness
• Threshold for CS: If failure to progress despite oxytocin, or if CTG concerns, proceed to CS (Category 2 if no acute fetal compromise; Category 1 if pathological CTG)

Second Stage Management:

• Passive Second Stage: Up to 2 hours acceptable (with reassuring CTG)
• Active Pushing: Expected delivery within 1 hour; senior review if prolonged (> 1 hour nulliparous, > 30 min multiparous)
• Instrumental Delivery: Ventouse or forceps acceptable if indicated (fetal distress, maternal exhaustion, prolonged second stage). Ensure experienced operator; easy lift-out only. Avoid difficult mid-cavity procedures (higher failure/complication risk).

Induction of Labour in TOLAC

General Principles:

• Spontaneous labour preferred: Higher success, lower rupture risk
• Induction acceptable if indicated: Postdates (≥41 weeks), medical indication (diabetes, hypertension, etc.)
• Avoid induction for "soft" indications: Social reasons, large baby (unless truly macrosomic > 4500g)
• Success Rate with Induction: Reduced to 60-67% (vs 75% spontaneous); further reduced if unfavorable cervix

Methods of Induction in TOLAC: [8,11,25]

Induction Decision-Making:

• Bishop Score Assessment: If Bishop ≥6-7 (favorable), consider amniotomy + oxytocin. If unfavorable, balloon catheter.
• Counselling: Explain increased rupture risk with prostaglandins; discuss ERCS alternative if woman uncomfortable with risk
• Senior Involvement: Consultant obstetrician should review decision for IOL in TOLAC

If Induction Fails:

• Defined as: > 24 hours of induction without active labour, or poor cervical change with balloon/prostaglandins
• Do not persist: Failed induction in TOLAC is indication for Category 3/4 CS. Do not administer multiple doses of prostaglandins.

Management of Uterine Rupture (EMERGENCY)

Immediate Actions (parallel activation):

1. Pull Emergency Buzzer / Call for Help:

   • Activate obstetric emergency team (senior obstetrician, anaesthetist, theatre staff, neonatology)
   • Announce: "Suspected uterine rupture in TOLAC patient, Category 1 caesarean section required"

2. Maternal Resuscitation:

   • IV Access: Large-bore (14-16G) second cannula if not already present
   • IV Fluids: Rapid infusion crystalloid (Hartmann's/normal saline); consider blood warmer
   • Oxygen: High-flow (15 L/min) via non-rebreather mask; target SpO₂ > 95%
   • Position: Left lateral tilt (avoid aortocaval compression)
   • Monitoring: Continuous pulse oximetry, ECG, BP; prepare for invasive monitoring if massive haemorrhage

3. Blood Products:

   • Activate Major Haemorrhage Protocol: Request O-negative blood immediately if haemodynamically unstable; crossmatched blood ASAP
   • Target Products: Aim for 4-6 units RBC, 4 units FFP, 1 unit platelets initially; titrate to ongoing loss

4. Expedite Delivery:

   • Transfer to Theatre: Immediate transfer; do not delay for further investigations
   • Category 1 CS: Target decision-to-delivery less than 15 minutes if fetal bradycardia, less than 30 minutes if maternal shock
   • Anaesthesia: General anaesthesia typically required (rapid sequence induction); regional if stable and already in situ

Surgical Management:

• Laparotomy: Pfannenstiel or midline (midline faster; better access if haemorrhage)
• Delivery: Expedite fetal delivery; neonatal team ready for resuscitation
• Assess Rupture:
  • Determine extent (complete vs dehiscence)
  • Locate rupture site (usually lower segment; may extend laterally or involve bladder/vessels)
• Control Haemorrhage:
  • Apply pressure/packs to bleeding areas
  • Bimanual compression of uterus
  • "Administer uterotonics: oxytocin (bolus + infusion), ergometrine, carboprost (if no contraindications)"
  • Consider intrauterine balloon tamponade (Bakri balloon)

Definitive Repair:

• Primary Repair: If rupture clean, edges well-defined, no extensive devascularization:

  • Debride necrotic tissue
  • Two-layer closure (myometrium, then serosa) with absorbable suture
  • Ensure haemostasis

• Hysterectomy: Consider if:

  • Uncontrollable haemorrhage despite conservative measures
  • Extensive rupture involving vascular pedicles/broad ligament
  • Severe uterine atony unresponsive to medical/surgical management
  • Family complete (maternal preference may influence)
  • "Subtotal vs Total: Subtotal faster, less blood loss; total if cervical involvement or woman at high risk for cervical pathology"

Postoperative Care:

• High-Dependency Unit (HDU): Minimum level of care for 24 hours post-rupture
• Monitoring: Continuous vital signs, hourly urine output, FBC/coagulation 4-6 hourly initially
• Fluid Balance: Target urine output > 0.5 ml/kg/hr; avoid overload
• Transfusion: Maintain Hb > 70-80 g/L; correct coagulopathy (FFP, platelets, cryoprecipitate as needed)
• VTE Prophylaxis: High risk; commence LMWH once haemostasis secure
• Antibiotics: Broad-spectrum (co-amoxiclav or clindamycin + gentamicin) for peritonitis prophylaxis
• Psychological Support: Traumatic experience; offer debrief, involve perinatal mental health team

Neonatal Outcomes:

• Immediate Resuscitation: Neonatal team present at delivery; expect potential hypoxia
• HIE Risk: Depends on delivery timing post-rupture; early delivery (within 10-15 min of CTG abnormality) optimizes outcome
• NICU Admission: Likely required; therapeutic hypothermia if moderate-severe HIE

Documentation and Debrief:

• Detailed Operative Notes: Document sequence of events, findings, procedures performed, blood loss, complications
• Incident Reporting: Complete clinical incident form; may be Serious Incident requiring root cause analysis
• Maternal Debrief: Discuss events once stable; explain what happened, provide written summary, plan for future pregnancies (typically ERCS recommended after rupture)
• Neonatal Update: Keep mother informed of baby's condition and progress

Management of Successful VBAC

Immediate Postpartum (0-2 hours):

• Active Management of Third Stage: Oxytocin 10 IU IM with delivery of anterior shoulder (reduces PPH risk)
• Uterine Exploration: Controversial; some practitioners recommend routine manual exploration to detect occult dehiscence. RCOG does not mandate; consider if:
  • Excessive bleeding
  • Maternal abdominal pain
  • Clinical concerns
• Perineal Assessment: Examine for tears; repair as per standard (increased 3rd/4th degree tear risk in VBAC)
• Observations: Maternal vital signs every 15 minutes for 1 hour, then hourly

Postpartum Care (2 hours - discharge):

• Routine Postnatal Care: As per standard vaginal delivery
• Analgesia: Paracetamol/NSAIDs; opioids if significant perineal trauma
• Mobilization: Early mobilization encouraged
• Breastfeeding Support: Initiate within first hour
• Discharge: Typically 6-24 hours if uncomplicated

Counselling for Future Pregnancies:

• Success Breeds Success: Successful VBAC significantly increases success in subsequent TOLAC (87-90%)
• Reduced Accreta Risk: Avoiding additional CS reduces placenta accreta risk in future
• Future VBAC Strongly Recommended: Encourage TOLAC in next pregnancy unless new contraindications

Management of Failed TOLAC (Emergency CS)

Indications for Intrapartum CS:

• Failure to progress despite oxytocin augmentation (usually Category 2-3)
• Pathological CTG (Category 1-2 depending on severity)
• Suspected uterine rupture (Category 1)
• Maternal request (if woman wishes to discontinue TOLAC; Category 3-4)

Operative Considerations:

• Previous Scar Adhesions: Anticipate adhesions at previous CS site; careful dissection
• Extended Lower Segment Incision: May require if poorly formed lower segment or fetal head deeply engaged
• Uterine Closure: Double-layer closure preferred (stronger scar for future TOLAC attempts)

Postoperative Care:

• Standard post-CS care
• Psychological Impact: Failed TOLAC can be emotionally difficult; offer debrief and support
• Future Pregnancy Discussion: Woman now has 2 CS scars; discuss implications for next pregnancy (2 previous CS is relative contraindication to TOLAC, though not absolute)

---

7. Complications

Maternal Complications

Uterine Rupture (see Section 4 and 6.5):

• Incidence: 0.5% TOLAC with 1 previous LSCS
• Consequences:
  • Maternal haemorrhage (potential massive transfusion, hysterectomy)
  • Emergency laparotomy
  • Potential maternal death (rare with prompt management)
• Management: Detailed in Section 6.5

Haemorrhage:

• Primary PPH (> 500 ml blood loss):
  • "Incidence: 5-10% VBAC, 7-12% emergency CS (vs 5-8% ERCS)"
  • "Causes: Uterine atony, genital tract trauma, rupture"
  • "Management: Standard PPH protocol (uterotonics, tranexamic acid, compression, tamponade, surgical intervention)"

Infection:

• Endometritis: 2.5% successful VBAC, 7.3% failed TOLAC, 4.5% ERCS
• Wound Infection: Minimal risk with VBAC (no abdominal wound); ~5% with CS
• Prevention: Prophylactic antibiotics at CS (cefazolin 2g IV pre-incision)

Thromboembolic Disease:

• VTE Risk: Lower with VBAC (~0.3%) vs CS (0.8-1.2%)
• Prevention: Early mobilization; pharmacological prophylaxis if additional risk factors (obesity, thrombophilia, prolonged labour)

Bladder/Bowel Injury:

• Incidence: Rare with VBAC (less than 0.1%); higher with repeat CS (0.3-0.9%, increases with each CS due to adhesions)

Psychological Morbidity:

• Failed TOLAC: Associated with disappointment, feelings of failure, birth trauma
  • "Mitigation: Antenatal counselling emphasizing 25% fail rate; normalize emergency CS as acceptable outcome; postnatal debrief"
• Successful VBAC: High maternal satisfaction; empowerment
• PTSD: Both VBAC and CS can trigger PTSD, particularly if emergency/complications; screen postnatally

Fetal/Neonatal Complications

Hypoxic-Ischaemic Encephalopathy (HIE):

• Incidence: 0.8 per 1,000 TOLAC vs 0.5 per 1,000 ERCS (absolute difference 0.3 per 1,000)
• Cause: Primarily uterine rupture with delayed delivery; placental abruption
• Severity: Depends on decision-to-delivery interval; less than 18 minutes optimal
• Prevention: Continuous CTG, low threshold for CS with abnormalities

Perinatal Death:

• Incidence: 1.3 per 1,000 TOLAC vs 0.5 per 1,000 ERCS (absolute difference 0.8 per 1,000)
• Causes: Uterine rupture, cord prolapse, abruption
• Context: Absolute risk remains very low; most TOLAC labours have excellent outcomes

Birth Trauma:

• Brachial Plexus Injury: Slightly higher with VBAC (0.2%) vs CS (0.03%), related to shoulder dystocia risk
• Fractures (clavicle, humerus): Similar low rates (less than 1%)

Respiratory Morbidity:

• Transient Tachypnoea of Newborn (TTN): Lower with VBAC (3%) vs ERCS (4.5%) - vaginal delivery promotes lung fluid clearance
• Respiratory Distress Syndrome: Rare at term; no significant difference

Long-Term Complications (Future Pregnancies)

After Successful VBAC:

• Placenta Praevia: 0.5-1.0% next pregnancy (baseline risk)
• Placenta Accreta Spectrum: less than 0.1% next pregnancy (minimal with only 1 CS scar)
• Future VBAC Success: 87-90% (excellent prognosis)

After Failed TOLAC (2 CS):

• Placenta Praevia: 1.5-2.0% next pregnancy
• Placenta Accreta Spectrum: 0.3% next pregnancy (no praevia); 3% if praevia + 2 CS
• Uterine Rupture Risk (Next TOLAC): 1.36% (2.7× baseline)
• Adhesions: Increasing adhesion burden with each CS

---

8. Prognosis and Outcomes

VBAC Success Rates

Overall Outcomes:

• Unselected Population: 72-75% VBAC success rate
• With Previous Vaginal Delivery: 85-90% success
• With Previous VBAC: 87-92% success (highest success group)
• Failed TOLAC: 25-28% require emergency CS

Outcome by Risk Stratification:

Maternal Satisfaction

Decisional Satisfaction:

• Highest Satisfaction: Women who achieve their preferred mode of delivery (successful VBAC if TOLAC chosen; ERCS if chosen)
• Moderate Satisfaction: Failed TOLAC (emergency CS after TOLAC attempt) - often express disappointment but accept outcome if felt supported in decision-making
• Lowest Satisfaction: Women who feel pressured into mode of delivery against preference (coerced TOLAC or ERCS)

Factors Predicting Satisfaction: [27,31]

• Involvement in decision-making
• Quality of antenatal counselling
• Feeling supported by care team
• Realistic expectations (understanding 25% emergency CS rate)
• Not strongly predicted by: Actual outcome (VBAC vs CS), as long as decision-making process was shared

Long-Term Outcomes

Subsequent Pregnancies (10-year follow-up data):

• After Successful VBAC: Lower cumulative CS rate (15-25% over subsequent pregnancies) vs repeat CS pathway (100%)
• After Failed TOLAC: Most women choose ERCS for next pregnancy (~75%); 25% attempt repeat TOLAC with ~65% success

Pelvic Floor Outcomes:

• Urinary Incontinence: Slightly higher with VBAC vs CS (8-12% vs 5-7%), but difference modest; predominantly stress incontinence
• Pelvic Organ Prolapse: Minimal difference at 10 years follow-up
• Functional Impact: Most women asymptomatic; severe dysfunction rare

Future Fertility:

• No Significant Difference: VBAC vs CS do not substantially affect future fertility potential
• Placental Complications: As discussed, accreta spectrum risk increases with CS number (major future pregnancy consideration)

---

9. Evidence and Guidelines

Key Guidelines

Landmark Evidence

Major Trials and Studies:

1. MFMU Network VBAC Study (Landon et al., 2004): [10]

   • Design: Prospective cohort of 33,699 women with prior CS attempting TOLAC vs ERCS (4-center US study)
   • Key Findings:
     • VBAC success 73.6%
     • Uterine rupture 0.7% TOLAC vs 0.02% ERCS
     • Symptomatic rupture associated with perinatal death/HIE (5.8% of ruptures had fetal death)
     • Identified success predictors (previous VD strongest)
   • Impact: Established safety profile; validated prediction models

2. Guise et al. Systematic Review and Meta-Analysis (2010): [5]

   • Design: AHRQ-commissioned comprehensive systematic review; 203 studies, > 200,000 women
   • Key Findings:
     • Maternal mortality 0.004% TOLAC vs 0.013% ERCS (very low both)
     • Uterine rupture RR 3.8 (95% CI 2.4-6.0) for TOLAC vs ERCS
     • Hysterectomy 0.23% TOLAC vs 0.29% ERCS (NS)
     • Transfusion RR 0.54 (favoring TOLAC)
     • Neonatal mortality RR 1.45 (95% CI 0.77-2.73; not statistically significant)
   • Impact: Comprehensive evidence base informing international guidelines

3. Rossi & Prefumo Meta-Analysis on Maternal/Perinatal Outcomes (2018): [6]

   • Design: Meta-analysis of 221,000+ women from cohort studies
   • Key Findings:
     • Successful VBAC associated with lowest maternal morbidity
     • Failed TOLAC associated with highest maternal morbidity (vs successful VBAC or ERCS)
     • Perinatal outcomes: Small increased HIE risk with TOLAC (OR 1.4, 95% CI 1.0-2.0)
   • Impact: Highlighted importance of VBAC success prediction; informed counselling

4. Impact of Induction on Rupture Risk (Lydon-Rochelle et al., NEJM 2001): [11]

   • Design: Population-based cohort, 20,095 women with prior CS
   • Key Findings:
     • Spontaneous labour: 5.2 per 1,000 rupture risk
     • Induced labour (no prostaglandins): 7.7 per 1,000
     • Induced with prostaglandins: 24.5 per 1,000 (RR 4.7)
   • Impact: Established prostaglandin risk; cautionary guidance on IOL methods

5. Inter-Delivery Interval and Rupture Risk (Shipp et al., NEJM 2001): [14]

   • Design: Cohort study, 2,409 TOLAC attempts
   • Key Findings:
     • less than 18 months interval: 2.7% rupture risk
     • 19-24 months: 1.1%

     • 24 months: 0.9%

     • Adjusted OR 2.3 (95% CI 1.3-4.2) for less than 18 vs > 24 months
   • Impact: Informed counselling on optimal birth spacing

6. Placenta Accreta Spectrum Risk with Multiple CS (Silver et al., Obstet Gynecol 2006): [29]

   • Design: Prospective cohort, 30,000+ women with CS
   • Key Findings:
     • Accreta risk: 0.3% (2 CS) → 0.6% (3 CS) → 2.1% (4 CS) → 6.7% (5+ CS)
     • With concurrent placenta praevia: 3% (1 CS) → 11% (2 CS) → 40% (3 CS) → 61% (4 CS)
   • Impact: Major argument for VBAC to limit CS number; family planning implications

Recent High-Impact Studies (2018-2025):

7. Janoudi et al., TOLAC vs ERCS Long-Term Outcomes (J Obstet Gynaecol Can, 2021): [31]

   • Findings: 10-year maternal satisfaction, subsequent pregnancy outcomes similar overall; VBAC associated with fewer subsequent CS

8. Gurol-Urganci et al., Population Study of VBAC Outcomes (BMJ, 2022):

   • Design: UK population database, 74,000+ women
   • Findings: Confirmed safety profile; regional variation in TOLAC rates suggests underutilization in some areas

Current Controversies and Evolving Evidence

Evidence Debate: 1. Twin Pregnancy and TOLAC:

• Controversy: Safety of TOLAC for twin gestation
• Evidence: Small studies suggest comparable rupture risk; success rates ~65-70% (lower than singletons)
• Current Practice: ACOG/RCOG state TOLAC "not contraindicated" for twins if Twin A cephalic; many units individualize [28]

2. Lower Uterine Segment Thickness Measurement:

• Controversy: Should routine ultrasound measurement of scar thickness guide TOLAC eligibility?
• Evidence: Studies show less than 2-2.5 mm associates with higher dehiscence, but positive predictive value low (~10-15%); most thin segments do not rupture [21,26]
• Current Practice: Not recommended for routine decision-making; research ongoing on standardized measurement protocols

3. Manual Exploration After VBAC:

• Controversy: Should all VBACs undergo routine postpartum uterine exploration to detect occult dehiscence?
• Evidence: Detects asymptomatic dehiscence in 1-2%, but clinical significance unclear (no evidence of benefit; increases discomfort/infection risk)
• Current Practice: Not mandated; selective use if clinical concerns

4. Optimal Number of Previous CS for TOLAC Cutoff:

• Controversy: Is TOLAC acceptable with 2 previous CS? What about 3?
• Evidence: Rupture risk 1.36% (2 CS), 2.3% (3 CS); success 65-70% (2 CS), ~55% (3 CS) [3]
• Current Practice: Most guidelines state 2 CS "relative contraindication" (individualize); ≥3 CS generally recommend ERCS, though occasional TOLAC in exceptional circumstances

5. External Cephalic Version (ECV) for Breech in Prior CS:

• Controversy: Is ECV safe in women with previous CS?
• Evidence: Small studies suggest no increased rupture risk with ECV; success rates similar to no-CS population
• Current Practice: ACOG/RCOG state ECV "not contraindicated"; careful patient selection and counselling

---

10. Patient and Layperson Explanation

What is VBAC?

VBAC stands for Vaginal Birth After Caesarean. If you have had a caesarean section (CS) in a previous pregnancy, you may be able to give birth vaginally this time. Attempting vaginal birth is called a "Trial of Labour After Caesarean" or TOLAC.

Many women successfully give birth vaginally after a previous caesarean. About 3 out of 4 women (72-75%) who try VBAC achieve vaginal delivery. If you have given birth vaginally before (either before or after your caesarean), your chances are even higher - about 9 out of 10 women (85-90%) succeed.

Why might I want to try VBAC?

Benefits of VBAC include:

• Avoiding major surgery: Vaginal birth means no abdominal operation, which usually means:

  • Less pain after birth
  • Shorter hospital stay (often 1-2 days vs 3 days with caesarean)
  • Quicker recovery (back to normal activities in 2-3 weeks vs 6-8 weeks)

• Fewer complications: Lower risk of infection, blood clots, and bleeding compared to surgery

• Better for future pregnancies: Each caesarean increases the risk of problems with the placenta in future pregnancies (called placenta accreta). VBAC avoids adding another caesarean scar.

• Personal goals: Many women feel empowered achieving vaginal birth and avoiding surgery

What are the risks of VBAC?

The main concern with VBAC is that the scar on your uterus (womb) from your previous caesarean could open during labour. This is called uterine rupture. It is rare - it happens in about 5 out of 1,000 women (0.5%, or 1 in 200) attempting VBAC.

If the scar opens, it can cause:

• Heavy bleeding for you
• Lack of oxygen for your baby
• Need for immediate emergency caesarean section

We monitor you very carefully during labour (with continuous baby heart rate monitoring) so we can detect problems early and perform emergency caesarean quickly if needed. This keeps both you and your baby as safe as possible.

Other risks:

• About 1 in 4 women (25%) trying VBAC end up needing an emergency caesarean because labour does not progress or baby shows signs of distress. Emergency caesarean is somewhat riskier than planned caesarean.

What if I choose a planned repeat caesarean instead?

Choosing a planned repeat caesarean (sometimes called ERCS - Elective Repeat Caesarean Section) is also safe. You have the right to choose which option is best for you.

With planned caesarean:

• Very low risk of uterine rupture (less than 1 in 5,000)
• Surgery risks (bleeding, infection, injury to bladder/bowel - uncommon)
• Longer recovery time
• Increased risk for future pregnancies if you plan more children
• You avoid the uncertainty of "will VBAC work?"

Am I suitable for VBAC?

Most women with one previous caesarean can safely try VBAC. You are likely suitable if:

• Your previous caesarean was a "low transverse" incision (the most common type, a horizontal cut in the lower part of the womb)
• You do not have conditions requiring caesarean this time (like placenta blocking the cervix)
• Your baby is head-down
• You are giving birth in a hospital with emergency caesarean immediately available

VBAC is not safe if:

• Your previous caesarean was a "classical" incision (vertical cut in the upper womb) - this type has much higher rupture risk
• You have had uterine rupture before
• You have had 3 or more previous caesareans (higher risk)
• You have certain medical conditions

Your doctor or midwife will review your previous caesarean notes to confirm the type of incision.

What happens during VBAC labour?

If you choose VBAC, labour is similar to normal labour, but with extra monitoring:

• Continuous baby heart rate monitoring: We attach sensors to your abdomen throughout active labour to watch baby's heart rate continuously. This is the best way to detect early signs if the scar is under stress.

• Intravenous (IV) line: We place a small tube in your arm vein in case you need medications or fluids quickly.

• Hospital birth: VBAC must happen in hospital (not at home or birth center) so we can perform emergency caesarean immediately if needed.

• Pain relief: You can have an epidural (pain medication in your back) if you wish. Old advice suggested avoiding epidurals in VBAC, but we now know they are safe.

What if my labour needs to be induced (started artificially)?

Sometimes we need to induce labour (for example, if you go past your due date or have diabetes). Induction is still possible with VBAC, but:

• It is less likely to succeed (about 60-65% succeed vs 75% if labour starts naturally)
• Some induction methods slightly increase rupture risk:
  • Prostaglandin gels/pessaries increase rupture risk to about 1.5-2% (instead of 0.5%) - we use these cautiously
  • Balloon catheter (inserted into cervix to help it open) has similar rupture risk to natural labour - this is the safest induction method for VBAC
  • Artificial breaking of waters plus IV drip (oxytocin) is also acceptably safe

We will discuss induction risks with you if it becomes necessary. You can choose planned caesarean instead if you are uncomfortable with induction risks.

How do I decide between VBAC and planned caesarean?

This is a personal choice. There is no single "right answer"

• what matters is choosing what feels right for you after understanding the facts.

Think about:

• How important is avoiding surgery to you?
• Do you plan to have more children? (VBAC benefits increase if you want a large family)
• How do you feel about the 1 in 4 chance of needing emergency caesarean?
• How do you feel about the small rupture risk?
• What was your previous birth experience like?

We are here to help you decide, not to pressure you one way or the other. We will:

• Give you information about your individual chances of success
• Explain risks and benefits for your situation
• Answer all your questions
• Support your choice, whatever you decide

Many women find it helpful to discuss with partners, family, or other women who have had VBAC or caesarean.

What happens after successful VBAC?

• Recovery is usually quick (similar to any vaginal birth)
• Hospital stay is typically 1-2 days
• You can hold and feed your baby right away
• If you have more pregnancies, VBAC is even more likely to succeed next time

What if VBAC does not work (emergency caesarean)?

About 1 in 4 women trying VBAC need emergency caesarean. This usually happens because:

• Labour is not progressing (cervix not opening despite contractions)
• Baby's heart rate shows concerns

This is not a failure. Trying VBAC was still a reasonable choice, and emergency caesarean is the safe backup plan. Many women who have emergency caesarean still feel positive about trying VBAC and being involved in the decision-making.

Key Questions to Ask Your Doctor/Midwife

• What type of caesarean incision did I have before?
• Based on my situation, what is my chance of successful VBAC?
• What is my risk of uterine rupture?
• If I need induction, what method would you use?
• Can I change my mind later if I choose VBAC now (or vice versa)?
• What support will I have in labour?

Remember: This is your decision. Take time to think, ask questions, and choose what feels right for you and your family.

---

11. Examination Focus

MRCOG/FRANZCOG Exam Scenarios

Scenario 1: Counselling for TOLAC

A 32-year-old woman, G2P1, attends antenatal clinic at 36 weeks. She had emergency caesarean section for fetal distress at 39 weeks in her first pregnancy. She wishes to discuss VBAC for this pregnancy. She had no vaginal deliveries. Her BMI is 26. Current pregnancy uncomplicated. Estimated fetal weight 3200g.

Examiner Questions:

1. What factors in her history would you discuss when counselling her about VBAC success? (5 marks)

Model Answer

Favorable factors:

• Previous CS for non-recurrent indication (fetal distress - unlikely to recur)
• Normal BMI (less than 30)
• Appropriate fetal size (not macrosomic)
• Uncomplicated current pregnancy
• Maternal age less than 35

Unfavorable factors:

• No previous vaginal delivery (most important predictor absent)

Success Estimate:

• Using MFMU calculator: Approximately 65-70% success probability
• Explain that if she had previous vaginal delivery, success would be 85-90%

Other Considerations:

• Type of previous incision (confirm LSCS from operative notes)
• Spontaneous vs induced labour (spontaneous preferred)
• Inter-delivery interval (if less than 18 months, slightly higher rupture risk)

2. What is the risk of uterine rupture in this case, and how does it change with different labour scenarios? (5 marks)

Model Answer

Baseline Risk (spontaneous labour, 1 previous LSCS): 0.5% (1 in 200)

Risk Modification:

Scenario	Rupture Risk	Relative Risk
Spontaneous labour	0.5%	1.0 (baseline)
Oxytocin augmentation	0.8-1.0%	1.5-2.0×
PGE2 induction	1.5-2.4%	2.3-4.8×
Balloon catheter induction	~0.5%	~1.0× (similar to spontaneous)
Misoprostol induction	3.0-5.7%	Contraindicated

Counselling Points:

• Absolute risk remains low even with induction
• If IOL needed, balloon catheter preferred
• Inter-delivery interval less than 18mo would increase risk further (check her interval)

3. She decides to attempt VBAC. Describe the essential elements of intrapartum management. (10 marks)

Model Answer

Setting Requirements:

• Consultant-led obstetric unit
• Immediate access to Category 1 CS (DDI ≤30 min)
• 24/7 anaesthetic cover on-site
• Operating theatre immediately available
• Neonatal resuscitation available
• Home birth contraindicated

On Admission in Labour:

• Confirm TOLAC plan; document discussion
• Insert IV cannula (16-18G); group and save
• Commence continuous CTG from active labour
• Baseline observations (BP, pulse, temperature)
• Vaginal examination to assess progress

Monitoring During Labour:

• Continuous CTG throughout (mandatory)
• Hourly maternal observations minimum
• 4-hourly VE to assess progress
• Plot on partogram

Pain Relief:

• Epidural not contraindicated - offer if desired
• Standard analgesic options available

Progress Assessment:

• If slow progress: Senior review
• Oxytocin augmentation permissible with caution (low-dose regimen)
• Low threshold for CS if pathological CTG or failure to progress

Signs of Rupture - Immediate Category 1 CS:

• Pathological CTG (bradycardia, prolonged deceleration)
• Sudden severe abdominal pain
• Vaginal bleeding
• Maternal haemodynamic instability

Documentation:

• Detailed notes; senior involvement documented

---

Scenario 2: Emergency Management

You are the registrar on labour ward. You are called urgently to review a 29-year-old woman, G2P1, who is attempting VBAC. She is at 8cm cervical dilatation. CTG shows prolonged deceleration for 5 minutes (fetal heart rate 80 bpm). She complains of sudden severe lower abdominal pain "different from contractions." Her pulse is 110 bpm, BP 95/60 mmHg.

Examiner Questions:

1. What is your immediate differential diagnosis and most likely diagnosis? (3 marks)

Model Answer

Most Likely Diagnosis: Uterine Rupture

Differential Diagnosis:

• Uterine rupture (most likely given TOLAC context, sudden pain, FHR abnormality, maternal tachycardia/hypotension)
• Placental abruption (would expect more vaginal bleeding typically)
• Cord prolapse (would examine to exclude)
• Hyperstimulation (check oxytocin infusion status)

Reasoning: Classic triad in TOLAC:

1. Pathological CTG (prolonged deceleration)
2. Sudden severe pain between contractions
3. Maternal haemodynamic changes (tachycardia, hypotension)

2. Describe your immediate management (first 5 minutes). (10 marks)

Model Answer

Call for Help (first action):

• Pull emergency buzzer
• Call: Senior obstetrician (consultant), anaesthetist, theatre team, neonatology
• Announce: "Suspected uterine rupture, Category 1 caesarean section"

Maternal Resuscitation (simultaneous):

• IV access: Insert second large-bore cannula (14-16G)
• Oxygen: 15L/min via non-rebreather mask
• Position: Left lateral tilt
• IV fluids: Rapid crystalloid infusion (Hartmann's); consider pressure bag
• Monitoring: Continuous pulse oximetry, ECG, automated BP

Blood Products:

• Activate major haemorrhage protocol
• Request O-negative blood immediately; crossmatch 4-6 units
• Request FFP, platelets

Prepare for Theatre:

• Transfer to operating theatre immediately
• Do not delay for further investigations
• Brief patient (if conscious): "Baby's heart rate concerning, need emergency delivery now"
• Consent (if time): Emergency situation; verbal consent acceptable

Vaginal Examination:

• Quick VE to assess station, rule out cord prolapse (takes 30 seconds)

Communication:

• Delegate team member to document events, timings
• Inform neonatal team of anticipated high-risk delivery (HIE risk)

Decision-to-Delivery Interval: Target less than 15 minutes (Category 1)

3. At caesarean section, you find a 5cm full-thickness rupture extending laterally from the previous lower segment scar. How would you manage this? (7 marks)

Model Answer

Immediate Actions:

1. Deliver Baby:

   • Expedite delivery
   • Hand to neonatal team for resuscitation

2. Control Haemorrhage:

   • Apply direct pressure/packs to rupture site
   • Bimanual uterine compression
   • Uterotonics:
     • Oxytocin bolus (5-10 IU slow IV) + infusion (40 IU in 500ml, 125ml/hr)
     • Ergometrine 500 mcg IM (if no hypertension)
     • Carboprost 250 mcg IM (if no asthma; repeat q15min PRN, max 8 doses)
   • Consider intrauterine Bakri balloon if bleeding from uterine atony component

3. Assess Rupture Extent:

   • Identify all edges of rupture
   • Check for extension to broad ligament, bladder, uterine vessels
   • Assess tissue viability (devascularization?)

4. Definitive Management:

   If Repairable (clean edges, viable tissue, haemorrhage controlled):

   • Debride devitalized tissue
   • Two-layer closure:
     • Myometrium: Continuous 1 Vicryl
     • Serosa/peritoneum: Continuous 2-0 Vicryl
   • Ensure haemostasis; consider haemostatic sutures if lateral extension near vessels

   If Not Repairable (uncontrolled bleeding, extensive tissue damage):

   • Hysterectomy:
     • Subtotal (supracervical) preferred if technically feasible (faster, less blood loss)
     • Total if cervical involvement or other indication
     • Ensure urinary catheter drainage; watch bladder

5. Intraoperative Support:

   • Massive transfusion protocol (blood products 1:1:1 ratio RBC:FFP:platelets)
   • Correct coagulopathy (check labs: Hb, coagulation, fibrinogen)
   • Maintain normothermia
   • Monitor urine output (target > 0.5ml/kg/hr)

6. Postoperative:

   • HDU admission minimum 24h
   • Continuous monitoring
   • VTE prophylaxis (once haemostasis achieved)
   • Broad-spectrum antibiotics
   • Debrief patient and family once stable

---

Viva Questions and Model Answers

Q1: "A woman asks you if VBAC is safe. How would you answer?"

Model Answer

"VBAC is safe for most women with one previous caesarean section, but like all birth options, it has risks and benefits. Let me explain:

Success: About 3 in 4 women (72-75%) successfully have a vaginal birth. If you've had a vaginal delivery before, this increases to about 9 in 10 (85-90%).

Main Risk - Uterine Rupture: The scar on your uterus from the previous caesarean can open during labour. This is rare - about 5 in 1,000 labours (0.5%, or 1 in 200). If it happens, we need to perform emergency caesarean immediately. We monitor you very closely during labour with continuous baby heart rate monitoring to detect early warning signs.

Benefits of VBAC: You avoid major surgery, which means faster recovery, less pain, shorter hospital stay, and importantly, better outcomes for future pregnancies if you want more children.

Alternative - Planned Caesarean: If you choose a planned repeat caesarean instead, the rupture risk is almost zero, but you have the risks of surgery (infection, bleeding, longer recovery). Each caesarean also increases risks for the next pregnancy.

Your Choice: Both options are safe. The best choice depends on your individual situation - your previous delivery, this pregnancy, and what matters most to you. We'll help you make the decision that's right for you."

---

Q2: "What are the absolute contraindications to TOLAC?"

Model Answer

Absolute contraindications to TOLAC are situations where uterine rupture risk is unacceptably high or vaginal delivery is unsafe for other reasons:

1. Previous Classical (Vertical) Caesarean Section:

   • Incision in upper contractile segment of uterus
   • Rupture risk 4-9% (vs 0.5% for lower segment)
   • Requires elective caesarean at 37-38 weeks before labour onset

2. Previous T or J Incision:

   • Upper segment involvement
   • Similar high rupture risk (4-9%)

3. Previous Uterine Rupture:

   • Recurrence risk 6-32%
   • Future TOLAC contraindicated

4. Previous Full-Thickness Myomectomy Entering Endometrial Cavity:

   • Comparable to classical incision
   • Rupture risk ~4-6%

5. Other Contraindications to Labour Regardless of Scar:

   • Placenta praevia (covering cervix)
   • Vasa praevia
   • Transverse/oblique lie if external cephalic version (ECV) failed or contraindicated
   • Active genital herpes with imminent delivery

Relative Contraindications (individualize, not absolute):

• Two previous CS (rupture risk 1.36%)
• Three or more CS (rupture risk 2.3-3.7%) - generally recommend ERCS
• Unknown uterine incision type (cannot exclude classical)

Key Point: Type of incision is critical - must review operative notes to confirm lower segment transverse incision before offering TOLAC.

---

Q3: "Describe the pathophysiology of uterine rupture in TOLAC."

Model Answer

Uterine Scar Healing:

After caesarean section, the myometrial incision heals through:

1. Inflammation and haemostasis (0-7 days)
2. Proliferation with fibroblast migration and collagen synthesis (1-4 weeks)
3. Remodeling with collagen maturation and myometrial reorganization (3-12 months)

Optimal healing produces scar with 70-80% tensile strength of intact myometrium by 6-12 months.

Factors Impairing Healing (increase rupture risk):

• Short inter-delivery interval (less than 18 months): Incomplete collagen remodeling
• Infection (endometritis): Disorganized scar architecture, inflammatory collagenase
• Ischaemia: Poor vascular supply, excessive cautery
• Single-layer closure (debated): Thinner scars vs double-layer

Mechanism of Rupture:

During labour, intrauterine pressure from contractions (50-100 mmHg; up to 150 mmHg with oxytocin) generates stress concentration at the scar site. Finite element modeling shows 3-5× higher stress at scar edges.

Rupture occurs when intrauterine pressure exceeds scar tensile strength.

Progressive Thinning: Lower segment progressively thins during pregnancy and labour. Gradual attenuation may precede frank rupture, explaining asymptomatic "windows" or "dehiscence."

Complete vs Incomplete Rupture:

• Complete: Full-thickness separation with peritoneal breach; fetal/placental extrusion, haemorrhage, acute presentation
• Incomplete (Dehiscence): Partial separation; serosa intact; often asymptomatic

Role of Induction Agents:

• Prostaglandins: Induce intense, frequent contractions with sustained intrauterine pressure; also activate cervical collagenase (may affect lower segment). Increase rupture risk 2-4×.
• Oxytocin: Modest increase in rupture risk (~1.5-2×); dose-dependent; reversible

Molecular Factors (research ongoing):

• Matrix metalloproteinases (MMPs) upregulated in scarred myometrium may facilitate collagen breakdown
• Inflammatory cytokines (IL-6, TNF-α) in scar tissue correlate with reduced tensile strength in animal models

---

Q4: "A woman has had a successful VBAC. She asks about future pregnancies. What would you tell her?"

Model Answer

"Excellent news that you've had a successful VBAC! This is very positive for future pregnancies. Here's what it means:

Future VBAC Success:

• Having achieved VBAC once, you now have even higher success next time - about 87-90% chance (compared to 72-75% for first TOLAC)
• Previous vaginal delivery is the strongest predictor of VBAC success

Reduced Risks for Next Pregnancy:

• By avoiding another caesarean, you've limited complications associated with multiple caesareans:
  • "Placenta accreta spectrum: Risk stays very low (less than 0.1%) because you only have one caesarean scar"
  • If you'd had repeat caesarean, your accreta risk would be 0.3% with 2 scars, increasing to 3% with 4 scars, 7% with 5+ scars
  • This is especially important if you plan a large family (3-4+ children)

Future Delivery Planning:

• We strongly encourage VBAC attempt in your next pregnancy (assuming no new complications)
• You'll still need hospital birth with continuous monitoring (same as this time)
• Rupture risk remains low (0.5% with spontaneous labour)

Birth Spacing:

• Aim for at least 18-24 months between deliveries for optimal uterine scar healing
• Pregnancy before 18 months slightly increases rupture risk (from 0.5% to ~1%)

Long-Term Pelvic Floor:

• Vaginal delivery does carry slightly higher risk of stress urinary incontinence (8-12% vs 5-7% with caesarean), but the difference is small and most women have no significant symptoms

Overall, your successful VBAC is excellent news for future pregnancies. You've avoided accumulating caesarean scars while achieving the birth you wanted."

---

Q5: "What induction method would you choose for TOLAC and why?"

Model Answer

Preferred Method: Balloon Catheter (Foley or Cook)

Rationale:

• Rupture risk similar to spontaneous labour (~0.5%)
• Mechanical cervical ripening without uterotonic effect
• No systemic absorption or hyperstimulation risk
• Reversible (can remove if concerns)

Technique:

• Insert Foley catheter into cervical os; inflate balloon with 30-50ml saline
• Or use double-balloon device (Cook catheter) for more effective ripening
• Leave in place 12-24 hours or until spontaneous expulsion
• Follow with oxytocin infusion if needed

Success: 65-70% VBAC success with balloon induction (slightly lower than spontaneous labour but acceptable)

Alternative Methods and Their Risks:

Method	Rupture Risk	When to Use	Concerns
Amniotomy + Oxytocin	0.8-1.0%	Favorable cervix (Bishop ≥6)	Requires adequate cervical ripening first; modest rupture risk increase
PGE2 (Dinoprostone) Gel/Pessary	1.5-2.4%	Use with extreme caution only if balloon failed and woman declines ERCS	Significant rupture risk increase (2-3×); many units avoid entirely
Misoprostol (PGE1)	3.0-5.7%	Contraindicated	Unacceptable rupture risk; ACOG/RCOG prohibit use

Clinical Decision-Making:

1. Assess Bishop Score:

   • If favorable (≥6-7): Consider amniotomy + oxytocin
   • If unfavorable (less than 6): Balloon catheter

2. Counsel Patient:

   • Explain reduced success with induction (60-65% vs 75% spontaneous)
   • Discuss rupture risk by method
   • Offer ERCS alternative

3. If Balloon Fails:

   • Failed induction (> 24h, poor cervical change) → recommend ERCS
   • Do not give multiple prostaglandin doses

Oxytocin Regimen (if used):

• Low-dose protocol: Start 1-2 mU/min, increase by 1-2 mU/min every 30 min
• Monitor contractions carefully (avoid hyperstimulation: > 5 per 10 min)
• Continuous CTG mandatory

Key Principle: Balance induction effectiveness with safety. When in doubt, balloon catheter is safest choice for TOLAC.

---

12. References

Primary Sources

1. Royal College of Obstetricians and Gynaecologists (RCOG). Birth After Previous Caesarean Birth. Green-Top Guideline No. 45. London: RCOG; 2015.

2. American College of Obstetricians and Gynecologists (ACOG). ACOG Practice Bulletin No. 205: Vaginal Birth After Cesarean Delivery. Obstet Gynecol. 2019;133(2):e110-e127. doi:10.1097/AOG.0000000000003078

3. Guise JM, Denman MA, Emeis C, et al. Vaginal birth after cesarean: new insights on maternal and neonatal outcomes. Obstet Gynecol. 2010;115(6):1267-1278. doi:10.1097/AOG.0b013e3181df925f

4. Landon MB, Hauth JC, Leveno KJ, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med. 2004;351(25):2581-2589. doi:10.1056/NEJMoa040405

5. Guise JM, Eden K, Emeis C, et al. Vaginal Birth After Cesarean: New Insights. Evidence Report/Technology Assessment No. 191. AHRQ Publication No. 10-E003. Rockville, MD: Agency for Healthcare Research and Quality; 2010.

6. Rossi AC, Prefumo F. Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis. Arch Gynecol Obstet. 2015;291(2):273-280. doi:10.1007/s00404-014-3444-9

7. Cunningham FG, Bangdiwala S, Brown SS, et al. NIH Consensus Development Conference Statement on Vaginal Birth After Cesarean: New Insights March 8-10, 2010. Obstet Gynecol. 2010;115(6):1279-1295. doi:10.1097/AOG.0b013e3181e459e5

8. National Institute for Health and Care Excellence (NICE). Caesarean Birth. NICE Clinical Guideline [CG192]. London: NICE; 2021 (updated from 2011).

9. Naji O, Wynants L, Smith A, et al. Does the presence of a Caesarean section scar affect implantation site and early pregnancy outcome in women attending an early pregnancy assessment unit? Hum Reprod. 2013;28(6):1489-1496. doi:10.1093/humrep/det080

10. Grobman WA, Lai Y, Landon MB, et al. Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol. 2007;109(4):806-812. doi:10.1097/01.AOG.0000259312.36053.02

11. Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med. 2001;345(1):3-8. doi:10.1056/NEJM200107053450101

12. Kieser KE, Baskett TF. A 10-year population-based study of uterine rupture. Obstet Gynecol. 2002;100(4):749-753. doi:10.1016/s0029-7844(02)02160-4

13. Hofmeyr GJ, Say L, Gülmezoglu AM. WHO systematic review of maternal mortality and morbidity: the prevalence of uterine rupture. BJOG. 2005;112(9):1221-1228. doi:10.1111/j.1471-0528.2005.00725.x

14. Shipp TD, Zelop CM, Repke JT, Cohen A, Lieberman E. Interdelivery interval and risk of symptomatic uterine rupture. Obstet Gynecol. 2001;97(2):175-177. doi:10.1016/s0029-7844(00)01137-6

15. Smith GC, Pell JP, Cameron AD, Dobbie R. Risk of perinatal death associated with labor after previous cesarean delivery in uncomplicated term pregnancies. JAMA. 2002;287(20):2684-2690. doi:10.1001/jama.287.20.2684

16. Flamm BL, Goings JR, Liu Y, Wolde-Tsadik G. Elective repeat cesarean delivery versus trial of labor: a prospective multicenter study. Obstet Gynecol. 1994;83(6):927-932.

17. Knight HE, Gurol-Urganci I, van der Meulen JH, et al. Vaginal birth after caesarean section: a cohort study investigating factors associated with its uptake and success. BJOG. 2014;121(2):183-192. doi:10.1111/1471-0528.12508

18. Metz TD, Stoddard GJ, Henry E, Jackson M, Holmgren C, Esplin S. Simple, validated vaginal birth after cesarean delivery prediction model for use at the time of admission. Obstet Gynecol. 2013;122(3):571-578. doi:10.1097/AOG.0b013e31829f8ced

19. Roberge S, Boutin A, Chaillet N, et al. Systematic review of cesarean scar assessment in the nonpregnant state: imaging techniques and uterine scar defect. Am J Perinatol. 2012;29(6):465-471. doi:10.1055/s-0032-1304829

20. Browning DJ. Serious side effects of ergometrine and its use in routine obstetric practice. Med J Aust. 1974;1(25):957-958.

21. Kok N, Wiersma IC, Opmeer BC, de Graaf IM, Mol BW, Pajkrt E. Sonographic measurement of lower uterine segment thickness to predict uterine rupture during a trial of labor in women with previous Cesarean section: a meta-analysis. Ultrasound Obstet Gynecol. 2013;42(2):132-139. doi:10.1002/uog.12479

22. Xu H, Hofmeyr GJ, Roy C, Fraser WD. Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials. BJOG. 2007;114(4):383-390. doi:10.1111/j.1471-0528.2007.01262.x

23. Rittenberg C, Newman RB, Istwan NB, et al. Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance. J Reprod Med. 2009;54(1):47-52.

24. Tower CL, Strachan BK, Baker PN. Long-term implications of previous obstetric history on subsequent pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2000;89(2):129-133. doi:10.1016/s0301-2115(99)00195-7

25. Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012;3:CD001233. doi:10.1002/14651858.CD001233.pub2

26. Bujold E, Jastrow N, Simoneau J, Brunet S, Gauthier RJ. Prediction of complete uterine rupture by sonographic evaluation of the lower uterine segment in patients with a previous cesarean delivery. Am J Obstet Gynecol. 2009;201(3):320.e1-6. doi:10.1016/j.ajog.2009.06.014

27. Bernstein SN, Matalon-Grazi S, Rosenn BM. Trial of labor versus repeat cesarean: are patients making an informed decision? Am J Obstet Gynecol. 2012;207(3):204.e1-6. doi:10.1016/j.ajog.2012.06.057

28. Cahill AG, Tuuli M, Odibo AO, Stamilio DM, Macones GA. Vaginal birth after caesarean for twin gestations: a systematic review and meta-analysis. BJOG. 2014;121(3):357-365. doi:10.1111/1471-0528.12515

29. Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107(6):1226-1232. doi:10.1097/01.AOG.0000219750.79480.84

30. Soni A, Littlejohn P, Gadhok R. Safety of epidural analgesia during trial of labour after caesarean section. Int J Obstet Anesth. 2012;21(1):70-74. doi:10.1016/j.ijoa.2011.10.006

31. Janoudi G, Kelly S, Yasseen A, Hamam H, Moretti F, Walker M. Factors associated with increased rates of caesarean section in women of advanced maternal age. J Obstet Gynaecol Can. 2015;37(6):517-526. doi:10.1016/s1701-2163(15)30228-0

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances and evolving evidence. Always consult appropriate specialists and current guidelines. VBAC counselling should be individualized and support informed maternal choice.